Description:

ECOG Non-Protocol Therapy Form NCT00520975 First-Line Chemotherapy and Trastuzumab With or Without Bevacizumab in Treating Patients With Metastatic Breast Cancer That Overexpresses HER-2/NEU Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=1720CDCE-4815-5A14-E044-0003BA3F9857

Link:

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=1720CDCE-4815-5A14-E044-0003BA3F9857

Keywords:
Versions (3) ▾
  1. 8/26/12
  2. 1/9/15
  3. 6/16/15
Uploaded on:

June 16, 2015

DOI:
No DOI assigned. To request one please log in.
License:
Creative Commons BY-NC 3.0 Legacy
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

ECOG Non-Protocol Therapy Form NCT00520975

INSTRUCTIONS: Use this form to capture the first occurrence of non-protocol anti-tumor therapy per registration step

Header
Reporting Period
Patient demographics
Off protocol treatment
Non-protocol Chemotherapy
Non-protocol Hormonal Therapy
Non-protocol Immunotherapy (Biological Response Modifiers)
Non-protocol High Dose Chemotherapy/Stem Cell Transplant (Autologous or Allogeneic)
Non-protocol Surgery
Non-protocol Radiation Therapy
Other Non-protocol Therapy
Was the non-protocol therapy given for the disease of this protocol (NOTE: Treatment for a second primary in the same organ site would not be considered therapy for disease of this protocol.)
Comments

Similar models